Flagship Harbor Advisors’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-75
Closed -$1K 747
2020
Q3
$1K Sell
75
-200
-73% -$4.19K ﹤0.01% 1796
2020
Q2
$5K Hold
275
﹤0.01% 1559
2020
Q1
$3K Buy
275
+95
+53% +$2.66K ﹤0.01% 1526
2019
Q4
$7K Hold
180
﹤0.01% 1422
2019
Q3
$8K Hold
180
﹤0.01% 1338
2019
Q2
$9K Buy
+180
New +$10.6K ﹤0.01% 1322

Other funds holding CLB

Flagship Harbor Advisors's CLB Position: Q4 2020 in Review

Flagship Harbor Advisors sold out of Core Laboratories (CLB) in Q4 2020, closing a stake of 75 shares — an estimated $1K sold.

Flagship Harbor Advisors first reported a position in CLB in Q2 2019 and held it in 6 quarters. The position peaked at $9K in Q2 2019. 181 funds tracked by Wall St. Rank hold CLB as of Q4 2020.

  • Flagship Harbor Advisors reported no remaining Core Laboratories position as of Q4 2020 after selling out during the quarter.
  • Flagship Harbor Advisors sold 75 Core Laboratories shares in Q4 2020, an estimated $1K.
  • Flagship Harbor Advisors first reported a position in Core Laboratories in Q2 2019 and held it in 6 quarters.
  • Flagship Harbor Advisors's Core Laboratories position peaked at $9K in Q2 2019.
  • 181 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2020.

Based on Flagship Harbor Advisors's 13F filing for Q4 2020, filed 8 Feb 2021.